Indolent Systemic Mastocytosis Clinical Trials in Berlin
2 recruitingBerlin, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Indolent Systemic MastocytosisSmoldering Systemic Mastocytosis
Blueprint Medicines Corporation534 enrolled64 locationsNCT04910685
Recruiting
A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
Indolent Systemic Mastocytosis
Blueprint Medicines Corporation80 enrolled8 locationsNCT07255638